HYDROMORPHONE HYDROCHLORIDE
HYDROMORPHONE HYDROCHLORIDE
Approval overview HYDROMORPHONE HYDROCHLORIDE is listed in Drugs@FDA under application 217812 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient HYDROMORPHONE HYDROCHLORIDE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 40MG/20ML (2MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2025-12-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview HYDROMORPHONE HYDROCHLORIDE is listed in Drugs@FDA under application 217812 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient HYDROMORPHONE HYDROCHLORIDE Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 40MG/20ML (2MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.